The regulatory mechanism of UCP2 toward the mammalian target of rapamycin (mTOR) and hypoxia‐inducible factor‐1 alpha (HIF‐1α) signaling in NSCLC was confirmed through western blotting. Here, UCP2 is linked to non-small cell lung carcinoma.